pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • RIVASTIGMINE TARTRATE
    RIVASTIGMINE TARTRATE
    no indication AUROBINDO PHARMA
  • Preclinical
    RK-33
    Triple-Negative Breast Cancer (TNBC) Natsar Pharmaceuticals Inc
  • Phase 1
    RLA-23174
    Kidney Fibrosis Rila Therapeutics Inc
  • Phase 2
← prev
page 127 of 231
next →
131
Pain89
Neurology1
RLF-TD011
Dystrophic Epidermolysis Bullosa
$RLFTY MindMaze Therapeutics Holding SA
  • Phase 2
    RLS-1496
    Actinic (Solar) Keratosis Rubedo Life Sciences Inc
  • Phase 2
    RM-718
    Obesity$RYTM RHYTHM PHARMACEUTICALS, INC.
  • Phase 2
    RN-0361
    Familial Chylomicronemia (Type I Hyperlipoproteinemia) Rona Therapeutics Inc
  • Preclinical
    RNA Nanoparticle Gene Therapy
    Craniofacial Bone Defects University of Iowa
  • Preclinical
    RNAT-89
    Anemia in Chronic Kidney Disease (Renal Anemia) RNA Therapeutics Inc
  • Phase 2
    RNDP-001
    Parkinson's Disease Kenai Therapeutics Inc
  • Phase 2
    RNK-05047
    Diffuse Large B-Cell Lymphoma Ranok Therapeutics Co Ltd
  • Phase 2
    RNS-60
    Acute Ischemic Stroke Revalesio Corp
  • Preclinical
    RO-104
    Wet (Neovascular / Exudative) Macular Degeneration RevOpsis Therapeutics Inc
  • Phase 1
    ROSE-12
    Solid Tumor Chugai Pharmaceutical Co Ltd
  • ROSYRAH
    ROSYRAH (LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL)
    no indication XIROMED
  • Preclinical
    RP-001
    Breast Cancer Recurv Pharma Inc
  • Phase 2
    RP-323
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) PhorMed Inc
  • Phase 3
    RP-901
    Osteoarthritis Risen(Shanghai) Pharma Tech Co Ltd
  • Phase 2
    RPA-501
    Glycogen Storage Disease (GSD)$RCKT ROCKET PHARMACEUTICALS, INC.
  • Phase 1
    RPA-601
    Cardiomyopathy$RCKT ROCKET PHARMACEUTICALS, INC.
  • Phase 1
    RPA-701
    Dilated Cardiomyopathy$RCKT ROCKET PHARMACEUTICALS, INC.
  • Phase 2
    RPESCRPE-4W
    Dry (Atrophic) Macular Degeneration Luxa Biotechnology LLC
  • Phase 1
    RQ-01
    Coronavirus Disease 2019 (COVID-19) Red Queen Therapeutics Inc
  • Preclinical
    RS-5
    Soft Tissue Sarcoma Resolute Science Inc
  • Preclinical
    RSBT-001
    Coronavirus Disease 2019 (COVID-19) RS BioTherapeutics Inc
  • Phase 2
    RSLV-132
    Post-Acute Sequelae of COVID 2019 (PASC or Long COVID) Resolve Therapeutics LLC
  • Preclinical
    RSV DT-preF
    Respiratory Syncytial Virus (RSV) Infections Calder Biosciences Inc
  • Phase 1
    RSY-248
    Enteritis Rasayana Therapeutics Inc
  • Preclinical
    RT-002
    Sarcopenia Ridgeline Therapeutics LLC
  • Phase 2
    RT-100
    Systolic Heart Failure (HFrEF) Renova Therapeutics Inc